Hyperion DeFi, Inc. (HYPD)Healthcare | Biotechnology | New York, United States | NasdaqCM
4.46 USD
+0.55
(14.067%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 4.53 +0.07 (1.570%) ⇧ (April 17, 2026, 7:39 p.m. EDT) Short-term: ★★☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 9:48 p.m. EDT
Despite aggressive revenue growth headlines and a recent price bounce off 2026 lows, the technical signals are heavily bearish with a model predicting an ~8% drop over the next 45 days, and the fundamental picture remains precarious with the stock trading below its 200-day average and negative earnings per share. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.139709 |
| AutoETS | 0.160955 |
| AutoTheta | 0.448970 |
| AutoARIMA | 0.724504 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 80% |
| H-stat | 0.39 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.557 |
| Excess Kurtosis | -0.73 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 20.737 |
| Revenue per Share | 0.163 |
| Market Cap | 50,806,736 |
| Beta | 2.63 |
| Previous Name | Eyenovia, Inc. |
| Website | https://hyperiondefi.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 3.1682243 |
| Address1 | 295 Madison Avenue |
| Address2 | Suite 2400 |
| All Time High | 859.2 |
| All Time Low | 0.85 |
| Ask | 4.58 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 350,430 |
| Average Daily Volume3 Month | 401,396 |
| Average Volume | 401,396 |
| Average Volume10Days | 350,430 |
| Beta | 2.628 |
| Bid | 4.42 |
| Bid Size | 2 |
| Book Value | 4.73 |
| City | New York |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 4.46 |
| Current Ratio | 2.683 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 4.5999 |
| Day Low | 4.0 |
| Debt To Equity | 20.737 |
| Display Name | Hyperion DeFi |
| Earnings Call Timestamp End | 1,774,526,400 |
| Earnings Call Timestamp Start | 1,774,526,400 |
| Earnings Timestamp | 1,774,528,200 |
| Earnings Timestamp End | 1,778,848,200 |
| Earnings Timestamp Start | 1,778,848,200 |
| Ebitda | -17,447,514 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -3.031 |
| Enterprise To Revenue | 65.005 |
| Enterprise Value | 52,878,556 |
| Eps Trailing Twelve Months | -9.4 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 3.4758 |
| Fifty Day Average Change | 0.9842 |
| Fifty Day Average Change Percent | 0.28315783 |
| Fifty Two Week Change Percent | 316.82245 |
| Fifty Two Week High | 17.18 |
| Fifty Two Week High Change | -12.72 |
| Fifty Two Week High Change Percent | -0.7403958 |
| Fifty Two Week Low | 1.02 |
| Fifty Two Week Low Change | 3.44 |
| Fifty Two Week Low Change Percent | 3.372549 |
| Fifty Two Week Range | 1.02 - 17.18 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,516,890,600,000 |
| Float Shares | 9,666,153 |
| Free Cashflow | -9,045,627 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 9 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.62716 |
| Gross Profits | 510,165 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.28743 |
| Held Percent Institutions | 0.12385 |
| Implied Shares Outstanding | 11,391,645 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,738,540,800 |
| Last Split Factor | 1:80 |
| Long Business Summary | Hyperion DeFi, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States. The company offers Optejet, a topical ophthalmic medication dispensing platform services. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; Senju Pharmaceutical Co., Ltd. to develop and commercialize MicroPine, MicroLine, and Mydcombi; and agreement with Formosa Pharmaceuticals. Inc. for Co-Development of Clobetasol Propionate Ophthalmic Suspension (0.05%) for the Treatment of Acute Dry Eye Disease in the U.S. The company was formerly known as Eyenovia, Inc. and changed its name to Hyperion DeFi, Inc. in July 2025. Hyperion DeFi, Inc. was founded in 2014 and is based in New York, New York. |
| Long Name | Hyperion DeFi, Inc. |
| Market | us_market |
| Market Cap | 50,806,736 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_291491698 |
| Most Recent Quarter | 1,767,139,200 |
| Name Change Date | 2,026-04-18 |
| Net Income To Common | -46,999,216 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 50,578,903 |
| Number Of Analyst Opinions | 2 |
| Open | 4.09 |
| Operating Cashflow | -14,770,174 |
| Operating Margins | -36.092262 |
| Payout Ratio | 0.0 |
| Phone | 917 289 1117 |
| Post Market Change | 0.07000017 |
| Post Market Change Percent | 1.5695106 |
| Post Market Price | 4.53 |
| Post Market Time | 1,776,469,181 |
| Prev Name | Eyenovia, Inc. |
| Previous Close | 3.91 |
| Price Hint | 4 |
| Price To Book | 0.9429175 |
| Price To Sales Trailing12 Months | 62.457954 |
| Profit Margins | 0.0 |
| Quick Ratio | 2.483 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.55 |
| Regular Market Change Percent | 14.0665 |
| Regular Market Day High | 4.5999 |
| Regular Market Day Low | 4.0 |
| Regular Market Day Range | 4.0 - 4.5999 |
| Regular Market Open | 4.09 |
| Regular Market Previous Close | 3.91 |
| Regular Market Price | 4.46 |
| Regular Market Time | 1,776,456,001 |
| Regular Market Volume | 876,661 |
| Return On Assets | -0.41889 |
| Return On Equity | -3.24085 |
| Revenue Growth | 16.664 |
| Revenue Per Share | 0.163 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 11,391,645 |
| Shares Percent Shares Out | 0.106400006 |
| Shares Short | 1,211,749 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 1,915,352 |
| Short Name | Hyperion DeFi, Inc. |
| Short Percent Of Float | 0.111099996 |
| Short Ratio | 3.2 |
| Source Interval | 15 |
| State | NY |
| Symbol | HYPD |
| Target High Price | 8.25 |
| Target Low Price | 4.3 |
| Target Mean Price | 6.275 |
| Target Median Price | 6.275 |
| Total Cash | 6,443,467 |
| Total Cash Per Share | 0.566 |
| Total Debt | 8,514,743 |
| Total Revenue | 813,455 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -9.4 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 6.015975 |
| Two Hundred Day Average Change | -1.555975 |
| Two Hundred Day Average Change Percent | -0.25864053 |
| Type Disp | Equity |
| Volume | 876,661 |
| Website | https://hyperiondefi.com |
| Zip | 10,017 |